Genmab — Oktober 2019

[peter12]

Når de skriver "Our collaboration with Genmab potentially includes bispecific antibodies from three different classes: trans-activating, cis-activating and tumor-targeting antibodies", betyder det at de samarbejder om 3 stoffer ?

[nohope]

• potentially -

[E_L]

@Sukkeralf they do post the latest presentations used here now https://ir.genmab.com/download-library

[JørgenVarnæs]

nice. thx EL

[Sukkeralf]

I know - I was more thinking about audio from the presentation

[Sukkeralf]

Peter tror bare det er de tre områder de arbejder med, så det kan godt være flere

[E_L]

ok, but aren't recordings mostly done when a bank or something is hosting the presentation? and then they controll distribution

[E_L]

2 more videos to keep you entertained PLEIADES "the holey grail of medicine" https://www.youtube.com/watch?v=lx7x_vA7MkU

[E_L]

and GRIFFIN https://www.youtube.com/watch?v=rHx1I24cWPg

[E_L]

just in case you are not entertained enough with the price development... ;(

[peter12]

If you could find one with Rajkumar pls ?

[E_L]

[peter12]

Jeg kan se at man kan købe Biontech i dag i US. Den ligger omkring de 15$

[Helge_LarsenPI-redaktør]

E L: Your new library. http://www.proinvestor.com/index.php?p=debat_1&postid=77729

[E_L]

haha, always wanted my own library

[Helge_LarsenPI-redaktør]

You are welcome.

[bibob]

And E L. Your findings is awesome.. allways first with the news. :-). Thanks.

[Bulder]

Til inspiration: +101,1%. Läkemedelsbolaget Ra Pharmaceuticals rusade efter att den belgiska läkemedelsjätten UCB lagt ett bud på bolaget med en premie mot gårdagens stängningskurs om 112 procent. Flera analyshus däribland Guggenheim skriver att affären har potential att bidra med nytt hopp till sektorn.

[Helge_LarsenPI-redaktør]

Tak Bulder..jeg synker lige en ekstra gang.

[Helge_LarsenPI-redaktør]

Vi savner lidt i Genmab: http://www.proinvestor.com/debat/77742#postdiv77744